pdf Eskisehir Med J. 2021; 2 (1): 29-32
Yeliz Kaya, Eskisehir Osmangazi University, Faculty of Health Sciences, Department of Nursing, Eskisehir, Turkey
Yavuz Tokgöz, Eskisehir Osmangazi University, Faculty of Medicine, Department of Gynecology and Obstetrics, Reproductive Endocrinology and Infertility, Eskisehir, Turkey
Coşkun Kaya, Eskisehir City Hospital, Department of Urology, Eskisehir, Turkey
Tuğba Tahta, Ankara Medipol University, Vocational School Of Health Services, Ankara, Turkey
Ahmet Başar Tekin, Eskisehir Osmangazi University, Faculty of Medicine, Department of Gynecology and Obstetrics, Reproductive Endocrinology and Infertility, Eskisehir, Turkey
Introduction: The treatment agents used in assisted reproductive technology (ART) treatments could cause supra-physiologic hormone levels. We aimed to show if the ART could be a predisposing risk factor to be positive for Coronavirus Disease 2019 (COVID-19).
Methods: The data of the 43 infertility patients who were treated with ART between 1 March and 1 December 2020 at a Reproductive Endocrinology and Infertility Unit of a tertiary center were collected retrospectively. These patients were phoned and asked if they wanted to participate in the study; they were positive for COVID-19 or had a symptom of the illness.
Results: It was found that only 1 (2.4%) case had COVID-19 after the ART treatment, had a loss of smell and taste. The remaining treated 42 cases had no symptoms of COVID-19 or a diagnosis with COVID-19.
Conclusion: When turning to normal practice life, all patients should be evaluated for COVID-19 during pre, per, and post-treatment time in order to stop the ART and protect against the cases from the possible side effects of assisted reproductive treatments, especially the possible, but undefined, predisposition factor to COVID-19.
Key Words: Covid-19, assisted reproductive technology, risk factors, prognosis
Kaya Y, Tokgöz Y, Kaya C, et al. Could Assisted Reproductive Technology Be a Predisposing Risk Factor for COVID-19 Infection in Women? Eskisehir Med J. 2021; 2 (1): 29-32.